Grifols | GRFS - Trade Creditors


Grifols reported EUR987.75M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 843K 34K Sep/2025
Arca Biopharma USD 4.16M 1.95M Dec/2025
aTyr Pharma USD 55.07M 51.01M Dec/2025
Bio Path USD 4.9M 1.42M Sep/2025
Brainstorm Cell Therapeutics USD 7.07M 647K Dec/2025
Capricor Therapeutics 1.65M 1.06M Dec/2025
Cara Therapeutics USD 4.08M 1.65M Sep/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Immunic USD 7.92M 25K Sep/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Minerva Neurosciences USD 640K 305K Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
TherapeuticsMD USD 143K 4K Jun/2024